OR WAIT 15 SECS
March 20, 2017
Deloitte published its eighth annual Life Sciences: Accounting and Financial Reporting Update - Including Interpretive Guidance publication. Finance professionals in the life sciences often operate with uncertainty, with many changes and challenges throughout the year. These uncertainties and changes bring a need for additional financial reporting, including revenue recognition, leases, the definition of a business, and non-GAAP measures. The update illuminates significant reporting changes dealing with cost and pricing pressures, clinical and operational innovation, customer and consumer engagement, and regulatory compliance. The report speaks to these topics in order to help the industry navigate its challenges more easily.